Cell Therapy MFG Intern (Manufacturing) Intern
Arcellx
About this role
Arcellx is a clinical-stage biotechnology company focused on reimagining cell therapy for cancer and incurable diseases. The company emphasizes innovation, collaboration, and a mission-driven culture aimed at developing safer, more effective, and accessible immunotherapies.
Skills
About Arcellx
arcellx.comArcellx is a biopharmaceutical company developing next‑generation cell therapies for cancer and autoimmune diseases. With a proprietary technology platform, they aim to reimagine and "supercharge" cell therapy to pursue cures and improve patient outcomes. The company advances engineered cell therapy candidates through research and clinical development to address unmet medical needs. Arcellx emphasizes innovation in therapeutic design and clinical translation.
Recent company news
Simply Wall StreetGilead’s US$7.8b Arcellx Deal Deepens Cell Therapy Diversification
2 days ago
CNBCGilead to buy cancer therapy developer Arcellx for up to $7.8 billion
2 weeks ago
BioPharma DiveGilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy
2 weeks ago
STATGilead to buy Arcellx in nearly $8B deal
2 weeks ago
Business WireGilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
2 weeks ago
About Arcellx
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Arcellx.
Salary
$44k – $62k
per year
More jobs at Arcellx
Similar Jobs
Manufacturing Associate II - Second Shift
Immatics
Chief Financial Officer
Lyell Immunopharma
Senior Director Data Management (Contract)
Jasper Therapeutics
Senior Cell Therapy Supply Chain Specialist
Immatics
Senior Scientist, Cell Therapy TRC In Vivo Pharmacology
Bristol Myers Squibb
Cell Therapy Scientist
AstraZeneca